Novavax

$560.3M revenue • United States

Company Overview

Company Name

Novavax

Address

United States

Approx. Annual Revenue

$560.3M

About Novavax

Novavax is a global biotechnology company based in the United States. The company is focused on developing its R&D assets and establishing partnerships to leverage its proven vaccine technology, including its recombinant nanoparticle and Matrix-M™ adjuvant technology, to help protect health.

Frequently Asked Questions about Novavax

Advertising Pixels

  • LinkedIn Ad Pixel

Social Profiles

Key Decision Makers

Vinayak Krishna Associate Director, Clinical Outsourcing and Business Operations
LinkedIn
Hansu Dong Executive Director Clinical Outsourcing & Business Operations
LinkedIn
Chijioke Bennett. MD, MPH, MBA Executive Director, Clinical Development
LinkedIn